Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
Neurocrine(NBIX) stock is priced at $157.21, giving the company a market capitalization of 15.98B. It carries a P/E multiple of 22.89.
As of 2026-09-14, Neurocrine(NBIX) stock has fluctuated between $156.57 and $159.19. The current price stands at $157.21, placing the stock +0.4% above today's low and -1.2% off the high.
Neurocrine(NBIX) shares are trading with a volume of 479.07K, against a daily average of 981.99K.
During the past year, Neurocrine(NBIX) stock moved between $122.14 at its lowest and $186.12 at its peak.
During the past year, Neurocrine(NBIX) stock moved between $122.14 at its lowest and $186.12 at its peak.
NBIX News
Morgan Stanley raised the firm’s price target on Neurocrine (NBIX) to $183 from $182 and keeps an Equal Weight rating on the shares. The firm identifies NBIP-21...
...
Analyst ratings
90%
of 30 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.